Skip to main content

Table 1 TFDEGs and their relationship with OS, and their coefficients in LASSO regression model

From: Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer

Gene

Description

HR (95% CI)

P value

Coefficients

ZNF106 (ZNF474)

Zinc finger protein 106

1.45 (1.05–2.00)

0.025

0.217

OVOL1

Ovo-like zinc finger 1

1.48 (1.07–2.04)

0.018

0.103

CBX2

Chromobox homolog 2

1.38 (1.00–1.91)

0.047

0.048

NFKBIE

Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon

0.72 (0.52–0.99)

0.042

− 0.221

LEF1

Lymphoid enhancer-binding factor 1

0.70 (0.50–0.96)

0.029

− 0.169

KLF15

Kruppel-like factor 15

0.69 (0.50–0.95)

0.022

− 0.108

EGR3

Early growth response 3

0.56 (0.40–0.77)

 < 0.001

− 0.055

NR3C2

Nuclear receptor subfamily 3, group C, member 2

0.68 (0.49–0.94)

0.019

− 0.049

MEOX1

Mesenchyme homeobox 1

0.70 (0.50–0.96)

0.027

− 0.034

  1. TFDEGs Differentially expressed transcription factor family genes; OS Overall survival; LASSO Least absolute shrinkage and selection operator; HR Hazard ratio; 95% CI 95% confidence interval